Abstract
The research and use of psychedelic medicines to treat common mental health disorders has increased substantially in the past 2 decades. At the same time, knowledge is relatively uncommon among midwives regarding (1) the relative benefits of psychedelic-assisted therapy, (2) best practices associated with the delivery of psychedelic-assisted therapy, and (3) responsible integration of this potentially useful intervention into mental health treatment plans. The purpose of this review is to describe current applications of psychedelic medicines to treat common mental health disorders, to describe the current legal status of these medicines used in this context, and to explore the potential for midwifery practice in this area with further training. This article also addresses the disparities regarding LGBTQIA+ and BIPOC populations in relation to this topic and their historical exclusion from research and treatment access in this field.
Original language | English (US) |
---|---|
Pages (from-to) | 373-383 |
Number of pages | 11 |
Journal | Journal of Midwifery and Women's Health |
Volume | 67 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2022 |
Keywords
- MDMA
- PTSD
- depression
- ketamine
- midwives
- psilocybin
- psychedelics
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Maternity and Midwifery